BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 32930651)

  • 1. Brain Iron Assessment after Ferumoxytol-enhanced MRI in Children and Young Adults with Arteriovenous Malformations: A Case-Control Study.
    Iv M; Ng NN; Nair S; Zhang Y; Lavezo J; Cheshier SH; Holdsworth SJ; Moseley ME; Rosenberg J; Grant GA; Yeom KW
    Radiology; 2020 Nov; 297(2):438-446. PubMed ID: 32930651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brain iron deposition after Ferumoxytol-enhanced MRI: A study of Porcine Brains.
    Theruvath AJ; Aghighi M; Iv M; Nejadnik H; Lavezo J; Pisani LJ; Daldrup-Link HE
    Nanotheranostics; 2020; 4(4):195-200. PubMed ID: 32637297
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantification of Macrophages in High-Grade Gliomas by Using Ferumoxytol-enhanced MRI: A Pilot Study.
    Iv M; Samghabadi P; Holdsworth S; Gentles A; Rezaii P; Harsh G; Li G; Thomas R; Moseley M; Daldrup-Link HE; Vogel H; Wintermark M; Cheshier S; Yeom KW
    Radiology; 2019 Jan; 290(1):198-206. PubMed ID: 30398435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differentiation of benign and malignant lymph nodes in pediatric patients on ferumoxytol-enhanced PET/MRI.
    Muehe AM; Siedek F; Theruvath AJ; Seekins J; Spunt SL; Pribnow A; Hazard FK; Liang T; Daldrup-Link H
    Theranostics; 2020; 10(8):3612-3621. PubMed ID: 32206111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of ferumoxytol-based cerebral blood volume estimates using quantitative R
    Rivera-Rivera LA; Schubert T; Knobloch G; Turski PA; Wieben O; Reeder SB; Johnson KM
    Magn Reson Med; 2018 Jun; 79(6):3072-3081. PubMed ID: 29096054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cross-sectional and Longitudinal Assessment of Brain Iron Level in Alzheimer Disease Using 3-T MRI.
    Damulina A; Pirpamer L; Soellradl M; Sackl M; Tinauer C; Hofer E; Enzinger C; Gesierich B; Duering M; Ropele S; Schmidt R; Langkammer C
    Radiology; 2020 Sep; 296(3):619-626. PubMed ID: 32602825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebral blood volume mapping with ferumoxytol in dynamic susceptibility contrast perfusion MRI: Comparison to standard of care.
    Varallyay CG; Nesbit E; Horvath A; Varallyay P; Fu R; Gahramanov S; Muldoon LL; Li X; Rooney WD; Neuwelt EA
    J Magn Reson Imaging; 2018 Aug; 48(2):441-448. PubMed ID: 29314418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidental ferumoxytol artifacts in clinical brain MR imaging.
    Bowser BA; Campeau NG; Carr CM; Diehn FE; McDonald JS; Miller GM; Kaufmann TJ
    Neuroradiology; 2016 Nov; 58(11):1087-1091. PubMed ID: 27704163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multicenter Safety and Practice for Off-Label Diagnostic Use of Ferumoxytol in MRI.
    Nguyen KL; Yoshida T; Kathuria-Prakash N; Zaki IH; Varallyay CG; Semple SI; Saouaf R; Rigsby CK; Stoumpos S; Whitehead KK; Griffin LM; Saloner D; Hope MD; Prince MR; Fogel MA; Schiebler ML; Roditi GH; Radjenovic A; Newby DE; Neuwelt EA; Bashir MR; Hu P; Finn JP
    Radiology; 2019 Dec; 293(3):554-564. PubMed ID: 31638489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety of ferumoxytol in children undergoing cardiac MRI under general anaesthesia.
    Wise-Faberowski L; Velasquez N; Chan F; Vasanawala S; McElhinney DB; Ramamoorthy C
    Cardiol Young; 2018 Jul; 28(7):916-921. PubMed ID: 29848399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of Ferumoxytol in the Abdomen and Pelvis: A Dosing Study with 1.5- and 3.0-T MRI Relaxometry.
    Wells SA; Schubert T; Motosugi U; Sharma SD; Campo CA; Kinner S; Woo KM; Hernando D; Reeder SB
    Radiology; 2020 Jan; 294(1):108-116. PubMed ID: 31714191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential for differentiation of pseudoprogression from true tumor progression with dynamic susceptibility-weighted contrast-enhanced magnetic resonance imaging using ferumoxytol vs. gadoteridol: a pilot study.
    Gahramanov S; Raslan AM; Muldoon LL; Hamilton BE; Rooney WD; Varallyay CG; Njus JM; Haluska M; Neuwelt EA
    Int J Radiat Oncol Biol Phys; 2011 Feb; 79(2):514-23. PubMed ID: 20395065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gadolinium Brain Deposition after Macrocyclic Gadolinium Administration: A Pediatric Case-Control Study.
    Tibussek D; Rademacher C; Caspers J; Turowski B; Schaper J; Antoch G; Klee D
    Radiology; 2017 Oct; 285(1):223-230. PubMed ID: 28640695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MRI assessment of hepatic iron clearance rates after USPIO administration in healthy adults.
    Storey P; Lim RP; Chandarana H; Rosenkrantz AB; Kim D; Stoffel DR; Lee VS
    Invest Radiol; 2012 Dec; 47(12):717-24. PubMed ID: 23070094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative ferumoxytol-enhanced MRI in pregnancy: A feasibility study in the nonhuman primate.
    Zhu A; Reeder SB; Johnson KM; Nguyen SM; Fain SB; Bird IM; Golos TG; Wieben O; Shah DM; Hernando D
    Magn Reson Imaging; 2020 Jan; 65():100-108. PubMed ID: 31655139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contrast-enhanced magnetic resonance venography in pediatric patients with chronic kidney disease: initial experience with ferumoxytol.
    Luhar A; Khan S; Finn JP; Ghahremani S; Griggs R; Zaritsky J; Salusky I; Hall TR
    Pediatr Radiol; 2016 Aug; 46(9):1332-40. PubMed ID: 27059620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety Report of Ferumoxytol for Magnetic Resonance Imaging in Children and Young Adults.
    Muehe AM; Feng D; von Eyben R; Luna-Fineman S; Link MP; Muthig T; Huddleston AE; Neuwelt EA; Daldrup-Link HE
    Invest Radiol; 2016 Apr; 51(4):221-227. PubMed ID: 26656202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of ultrasmall superparamagnetic iron-oxide (USPIO) enhanced MRI with ferumoxytol to quantify arterial wall inflammation.
    Smits LP; Tiessens F; Zheng KH; Stroes ES; Nederveen AJ; Coolen BF
    Atherosclerosis; 2017 Aug; 263():211-218. PubMed ID: 28662398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of ferumoxytol magnetic resonance imaging on the rhesus macaque maternal-fetal interface†.
    Nguyen SM; Wiepz GJ; Schotzko M; Simmons HA; Mejia A; Ludwig KD; Zhu A; Brunner K; Hernando D; Reeder SB; Wieben O; Johnson K; Shah D; Golos TG
    Biol Reprod; 2020 Feb; 102(2):434-444. PubMed ID: 31511859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of ferumoxytol- and gadolinium chelate-enhanced MRI for assessment of sarcomas in children and adolescents.
    Siedek F; Muehe AM; Theruvath AJ; Avedian R; Pribnow A; Spunt SL; Liang T; Farrell C; Daldrup-Link HE
    Eur Radiol; 2020 Mar; 30(3):1790-1803. PubMed ID: 31844962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.